泰格捷通是泰格醫藥(股票代碼:300347.SZ/3347.HK)全資子公司，成立?于2000年，是中國領先的醫療器械(含體外診斷產品)法規事務及臨床研?究CRO服務提供商，覆蓋醫療器械各領域全生命周期。在過去的20年中，?我們與來自30多個國家的1700多家醫療器械研發及生產企業建立了長?期的合作關系。以我們專業的服務能力為客戶降低注冊風險、縮短項目?周期、節約研發經費，推進產品市場化進程。?
Tigermed-Jyton?,?a?wholly-owned?subsidiary?of?Tigermed?Group?(?Stock?code?:?300347.SZ/3347.HK?)?,?was?established?in?2000?,?and?is?a?leading?CRO?service?provider?in?China?for?regulatory?affairs?and?clinical?research?ofmedical?debices?(including?in?vitro?diagnostic?products)?,?with?service?covering?the?whole?life?cycle?of?all?fields?of?medical?devices.?In?the?past?20years,we?have?established?long-trem?cooperative?relations?with?more?than1,700?medical?device?R&D?and?manufacture?enterprises?from?more?than?30countries.?With?our?professional?service?capability,?we?can?reduce?registration?risk,?shorten?project?timeline,?save?R&D?funds?and?accelerate?the?process?of?product?marketization.